ProfileGDS4718 / 227387_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 49% 47% 53% 52% 44% 44% 54% 54% 51% 49% 48% 44% 44% 42% 49% 49% 42% 47% 43% 50% 48% 52% 49% 51% 44% 51% 44% 48% 42% 43% 44% 56% 52% 40% 45% 47% 50% 52% 49% 49% 44% 43% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4961350
GSM549102patient 115, normal, homogenized [OPG study]5.4897549
GSM549104patient 119, normal, homogenized [OPG study]5.3256447
GSM549108patient 138, normal, homogenized [OPG study]5.7446453
GSM549119patient 077, normal, homogenized [OPG study]5.6291752
GSM549133patient 032, cancer, homogenized [OPG study]5.1438344
GSM549139patient 042, cancer, homogenized [OPG study]5.160644
GSM549099patient 107, normal, homogenized [OPG study]5.743454
GSM549109patient 139, normal, homogenized [OPG study]5.7590554
GSM549110patient 046, normal, homogenized [OPG study]5.5872951
GSM549114patient 063, normal, homogenized [OPG study]5.4186549
GSM549122patient 082, normal, homogenized [OPG study]5.412748
GSM549134patient 033, cancer, homogenized [OPG study]5.167344
GSM549136patient 036, cancer, homogenized [OPG study]5.1392344
GSM549140patient 044, cancer, homogenized [OPG study]5.0351442
GSM549111patient 047, normal, homogenized [OPG study]5.4392649
GSM549113patient 057, normal, homogenized [OPG study]5.4043849
GSM549132patient 031, cancer, homogenized [OPG study]5.0562442
GSM549137patient 038, cancer, homogenized [OPG study]5.3120647
GSM549142patient 047, cancer, homogenized [OPG study]5.273943
GSM549100patient 110, normal, homogenized [OPG study]5.5037750
GSM549107patient 135, normal, homogenized [OPG study]5.367348
GSM549115patient 068, normal, homogenized [OPG study]5.5495952
GSM549116patient 072, normal, homogenized [OPG study]5.4287149
GSM549120patient 078, normal, homogenized [OPG study]5.5378451
GSM549131patient 030, cancer, homogenized [OPG study]5.1068544
GSM549118patient 074, normal, homogenized [OPG study]5.5412251
GSM549129patient 027, cancer, homogenized [OPG study]5.213344
GSM549123patient 088, normal, homogenized [OPG study]5.4108148
GSM549124patient 006, cancer, homogenized [OPG study]5.1426342
GSM549126patient 015, cancer, homogenized [OPG study]5.1365643
GSM549128patient 025, cancer, homogenized [OPG study]5.1668944
GSM549103patient 117, normal, homogenized [OPG study]5.8789256
GSM549117patient 073, normal, homogenized [OPG study]5.5808452
GSM549138patient 041, cancer, homogenized [OPG study]4.9757540
GSM549141patient 045, cancer, homogenized [OPG study]5.2122145
GSM549130patient 028, cancer, homogenized [OPG study]5.3608747
GSM549101patient 111, normal, homogenized [OPG study]5.5416250
GSM549105patient 128, normal, homogenized [OPG study]5.6188352
GSM549106patient 134, normal, homogenized [OPG study]5.4094449
GSM549112patient 048, normal, homogenized [OPG study]5.4485549
GSM549125patient 011, cancer, homogenized [OPG study]5.2162844
GSM549127patient 024, cancer, homogenized [OPG study]5.1189943
GSM549135patient 035, cancer, homogenized [OPG study]5.1392144